FLOT2 and neoplasm: When categorizing the patients by tumor growth (T stages), lymphatic metastasis (N stages), distant metastasis (M stages) and overall TNM stages, we found that Flot2 high expression was more frequent in patients with more advanced N stage (P < 0.001), M stage (P < 0.001), and overall TNM stage (P = 0.006).